FDA approves Orzeyful (oveporexton), first drug for narcolepsy type 1 targeting its root cause
FDA APPROVALSWhat just got approvedNew medicines reach patients every month. Here's what they treat, how they work, and what to watch, click any card for the full bite.The U.S. Food and Drug Administration approved Orzeyful (oveporexton) on August 5, 2026, for the treatment of narcolepsy type 1 in adults. It is the first drug approved […]
Read the Full Bite →